MedWatch

CRO-CEO: Outsourcing is all talk, no action

The CEO of a Danish CRO notices a general drop in activity in the business. He has spoken to Medwatch about the reasons for the slowdown in growth. Read what he had to say here.

“We have a lot of contacts in the big pharmaceutical companies, and it was always believed that something was on the verge of happening in regards to contract research, but time just keeps passing.”

Co-founder and CEO in the Contract Research Organization Gubra, Niels Vrang, puts it bluntly, when asked about the reason for the general slowdown in the market for contract research.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Dansk Biotek skifter navn

Den danske brancheorganisation for biotekselskaber, Dansk Biotek, skifter navn til "Danish Bio - Dansk Biotek" for at imødekomme den stigende internationalisering af branchen, fortæller formand.

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier